[ad_1] Eli Lilly ‘s raised guidance stole the show Tuesday, offsetting mixed first-quarter results and propelling shares higher by nearly 6%. The numbers leave little […]
Continue readingTag: Pfizer Inc
FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder
[ad_1] The Food and Drug Administration on Friday announced that the agency approved Pfizer‘s treatment for a rare genetic bleeding disorder, making it the company’s […]
Continue reading
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
[ad_1] The exterior view of the entrance to Merck headquarters in Rahway, New Jersey, on Feb. 5, 2024. Spencer Platt | Getty Images Merck on […]
Continue reading
Bristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly loss
[ad_1] The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, on Dec. 27, 2023. Adam Glanzman | Bloomberg | Getty […]
Continue reading
Biotech stocks are ready to break out. They just need one more thing
[ad_1] While debate rages on about when the Federal Reserve might start cutting interest rates, biotech industry analysts are making the case that the argument […]
Continue reading
Pfizer's RSV vaccine shows potential to protect high-risk adults ages 18-59, widening possible use
[ad_1] Respiratory syncytial virus – viral vaccine under research Hailshadow | Istock | Getty Images A vaccine from Pfizer showed the potential to protect adults […]
Continue reading
Moderna says new Covid vaccine showed stronger immune response than current shot in study
[ad_1] A nurse fills a syringe with Moderna Covid-19 vaccine. Fred Tanneau | Afp | Getty Images Moderna on Tuesday said a new version of […]
Continue reading
Pfizer is betting big on cancer drugs to turn business around after Covid decline – here's what to know
[ad_1] Nurphoto | Nurphoto | Getty Images Pfizer is ready to move on from Covid. Now, the company is betting on cancer drugs to help […]
Continue reading